Efficacy of T-cell transcription factor-specific DNAzymes in murine skin inflammation models

Journal of Allergy and Clinical Immunology

Volumn 137, Issue 2, 2016, Pages 644-647.e8

  Purath, Ulrich ^a   Ibrahim, Rouba ^b   Zeitvogel, Jana ^c   Renz, Harald ^b   Runkel, Frank ^d   Schmidts, Thomas ^d   Dobler, Dorota ^d   Werfel, Thomas ^c   Müller, Anke ^a   Garn, Holger ^b  

^a Sterna Biologicals GmbH and Co KG   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d TECHNISCHE HOCHSCHULE MITTELHESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; DEOXYRIBOZYME; HGD 40; HTD 70; INTERLEUKIN 13; MESSENGER RNA; OXAZOLONE; PLACEBO; SKIN PROTECTIVE AGENT; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTISENSE THERAPY; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG TARGETING; EXPERIMENTAL DERMATITIS; GENE EXPRESSION; HUMAN; HUMAN CELL; LETTER; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; OXAZOLONE-INDUCED DELAYED TYPE HYPERSENSITIVITY; PRIORITY JOURNAL; SKIN PROTECTION; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; TOPICAL TREATMENT; TRANSCRIPTION REGULATION; ANIMAL; DERMATITIS; DISEASE MODEL; GENETICS; IMMUNOLOGY; METABOLISM; PATHOLOGY; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; DERMATITIS; DISEASE MODELS, ANIMAL; DNA, CATALYTIC; MICE; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; TRANSCRIPTION FACTORS;

EID: 84957991496     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2015.09.022     Document Type: Article

References (10)

1. T. Nomura, K. Kabashima, and Y. Miyachi The panoply of αβT cells in the skin J Dermatol Sci 76 2014 3 9
2. J. Geginat, M. Paroni, F. Facciotti, P. Gruarin, I. Kastirr, F. Caprioli, and et al. The CD4-centered universe of human T cell subsets Semin Immunol 25 2013 252 262
3. S.K. Silverman In vitro selection, characterization, and application of deoxyribozymes that cleave RNA Nucleic Acids Res 33 2005 6151 6163
4. S. Sel, M. Wegmann, T. Dicke, W. Henke, A.O. Yildirim, H. Renz, and et al. Effective prevention and therapy of experimental allergic asthma using a GATA-3-specific DNAzyme J Allergy Clin Immunol 121 2008 910 916
5. N. Krug, J.M. Hohlfeld, A.M. Kirsten, O. Kornmann, K.M. Beeh, D. Kappeler, and et al. Allergen-induced asthmatic responses modified by a GATA3-specific DNAzyme N Engl J Med 372 2015 1987 1995
6. T. Schmidts, D. Dobler, P. Schlupp, C. Nissing, H. Garn, and F. Runkel Development of multiple W/O/W emulsions as dermal carrier system for oligonucleotides: effect of additives on emulsion stability Int J Pharm 398 2010 107 113
7. T. Schmidts, D. Dobler, S. von den Hoff, P. Schlupp, H. Garn, and F. Runkel Protective effect of drug delivery systems against the enzymatic degradation of dermally applied DNAzyme Int J Pharm 410 2011 75 82
8. Y. Yin, Y. Sun, L. Gu, W. Zheng, F. Gong, X. Wu, and et al. Jaceosidin inhibits contact hypersensitivity in mice via down-regulating IFNγ/STAT1/T-bet signaling in T cells Eur J Pharmacol 651 2011 205 211
9. K.M. Murphy, A.B. Heimberger, and D.Y. Loh Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo Science 250 1990 1720 1723
10. T. Schmidts, D. Dobler, P. Schlupp, C. Nissing, H. Garn, and F. Runkel Development of multiple W/O/W emulsions as dermal carrier system for oligonucleotides: effect of additives on emulsion stability Int J Pharm 398 2010 107 113